Non-lamellar lyotropic liquid crystalline nanoparticles as nanocarriers for enhanced drug encapsulation of atorvastatin calcium and proanthocyanidins
Atorvastatin calcium (ATV) and proanthocyanidins (PAC) have a strong antioxidant activity, that can benefit to reduce the atherosclerotic plaque progression. Unfortunately, the bioavailability of ATV is greatly reduced due to its limited drug solubility while the PAC drug is unstable upon exposure t...
Guardado en:
| Autores Principales: | Maslizan, Mardhiah, Haris, Muhammad Salahuddin, Ajat, Mokrish, Md Jamil, Siti Nurul Ain, Azhar, Shah Christirani, Zahid, N. Idayu, Mat Azmi, Intan Diana |
|---|---|
| Formato: | Artículo |
| Publicado: |
Elsevier BV
2024
|
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle
por: Maslizan, Mardhiah
Publicado: (2022) -
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle
por: Maslizan, Mardhiah
Publicado: (2022) -
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle /
por: Mardhiah Maslizan, -
Enzyme nanocarriers /
Publicado: (2015) -
Nanocarrier Technologies Frontiers of Nanotherapy /
Publicado: (2006)
